High-dose flu vaccine supply in Georgia running low amid coronavirus pandemic
The supply for high-dose flu vaccines that are recommended for those 65 years and older is “spotty,” a Georgia Health Department spokeswoman said.
Workers look to Social Security for retirement help as coronavirus sets back saving
Americans whose employment have been negatively impacted have far less savings, survey shows.
OxyContin maker Purdue Pharma agrees to plead guilty in $8B opioid settlement
OxyContin maker Purdue Pharma has agreed to plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.
Medicare open enrollment is here. This is what you need to know
Medicare’s annual 2020 enrollment period has just begun and ends on Dec. 7.
How a pioneering COVID testing lab helped keep Northeast colleges open
The Broad Institute regularly processes more than 70,000 tests a day—about 45,000 of them from colleges and universities—and has the capacity to go up to 100,000.
Rural Midwest hospitals struggling to handle COVID-19 surge
As the brunt of the virus has blown into the Upper Midwest and northern Plains, the severity of outbreaks in rural communities has come into focus.
WHO-backed study finds no remdesivir benefit for hospitalized COVID-19 patients
A multicountry study funded by the World Health Organization found that the antiviral drug remdesivir didn't reduce deaths from Covid-19 in hospitalized patients.
Dems acknowledge Barrett likely to be confirmed, warn of 'conservative judicial activism'
Democrats cautioned Wednesday that the confirmation of Supreme Court nominee Amy Coney Barrett could spark a new chapter of conservative judicial activism.
Trump strikes coronavirus vaccine deal for CVS, Walgreens to give shots to seniors
The Trump administration on Friday unveiled a deal with CVS and Walgreens to administer a future coronavirus vaccine to nursing home residents and staff free of cost.
Pfizer may apply for emergency use of COVID-19 vaccine by late November
The company expects to have data on the drug's safety by the third week of November.
Trump's election-eve drug discounts for seniors get snagged
One administration official said the odds are 75-25 the plan will not happen
Pelosi, Mnuchin reach agreement on Democrats' language for national COVID testing plan
A Treasury Department official familiar with the matter told FOX Business that the language of the plan will be shared on Friday.
Walmart now offering Medicare plans as election season heats up
America’s largest retailer, Walmart, is adding Medicare health insurance plans to its plethora of goods (or commodities). And with the start of this year’s Annual Enrollment Period (AEP), seniors can officially start enrolling through the company’s new brokerage.
Walgreens completes 1M coronavirus tests, ramps up corporate testing
Walgreens is offering COVID-19 tests to main street consumers and big businesses.
Regeneron gets approval for 1st Ebola virus treatment
Regeneron's treatment is a combination of three antibodies that work by killing the virus
Biden camp denies report that son-in-law advised on health policy while investing in coronavirus startups
Democratic presidential nominee Joe Biden's campaign pushed back on a report that the candidate's son-in-law advised the team on the coronavirus pandemic and health policy while simultaneously investing in health care startups.
FDA issues warning to 5 companies selling dietary supplements containing cesium chloride
The FDA requires companies to provide safety-related information about cesium chloride before it is included in a dietary supplement.
FDA faults quality control at Lilly plant making Trump-touted COVID drug
The Lilly antibody therapy, which is experimental and not yet approved by regulators as safe and effective, is similar to a drug from Regeneron Pharmaceuticals that was given to the president during his bout with COVID-19.
Johnson & Johnson coronavirus vaccine trial pause 'quite common,' Alex Azar says
The pause on Johnson & Johnson’s coronavirus vaccine research study, which is due to an adverse reaction by one of the participants, is “quite common” in vaccine clinical trials, Health and Human Services Secretary Alex Azar told “Varney & Co.” on Tuesday.
Eli Lilly pauses COVID-19 antibody trial, stock slides
Eli Lilly stock fell more than 4 percent following the news



















